Industry News, Trustworthy Insights

Popular Companies:

UBS Exclusive: Advisory on Haleon’s 33% Stake Acquisition in Tianjin TSKF Pharmaceutical for $636m

UBS has successfully guided Haleon in its strategic acquisition of a 33% stake in Tianjin TSKF Pharmaceutical Co., Ltd., a deal valued at $636 million.

The UBS logo captured in front of its office at UBS AG. PHOTO: Shutterstock
The UBS logo captured in front of its office at UBS AG. PHOTO: Shutterstock

This move is a key part of Haleon’s strategy to penetrate the Chinese market, which is seeing a spike in demand for healthcare products due to its aging population and expanding middle class.

By partnering with Tianjin TSKF,

Industry news used by professionals

Try £4.99 per month

Already a member?
Weekly Digest

All the week’s industry events straight to your inbox.

Before your sign up, please read terms of use and privacy policy.

Trending

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to our terms of use and privacy policy.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Password Reset

You will soon receive a Reset Password link

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to terms of use and privacy policy.

Send us your article

popup

Maximum file size: 2.1MB

Start Over